TITLE

The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma

AUTHOR(S)
Hellerbrand, C.; Amann, T.; Schlegel, J.; Wild, P.; Bataille, F.; Spruss, T.; Hartmann, A.; Bosserhoff, A-K.
PUB. DATE
February 2008
SOURCE
Gut;Feb2008, Vol. 57 Issue 2, p243
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Melanoma inhibitory activity 2 (MIA2) is a novel gene of the MIA gene family. The selective expression of MIA2 in hepatocytes is controlled by hepatocyte nuclear factor (HNF) 1 binding sites in the MIA2 promotor. In contrast, in most hepatocellular carcinomas (HCC) MIA2 expression is down-regulated or lost. Aim: In this study we examined the regulation and functional role of MIA2 in hepatocancerogenesis. Methods and results: In HCC cell lines and tissues HNF-1 expression was lower than in primary human hepatocytes (PHH) and corresponding non-tumorous tissue, respectively, and correlated significantly with the down-regulation of MIA2 expression. Re-expression of HNF-1 in HCC cells reinduced MIA2 in HCC cells to similar levels as found in PHH. Further, MIA2 was re-expressed in HCC cell lines by stable transfection, and the generated cell clones revealed a strongly reduced invasive potential and proliferation rate in vitro. In line with these findings treatment of F-ICC cells with recombinant MIA2 inhibited proliferation and invasion. In nude mice MIA2 re-expressing F-ICC cells grew significantly slower and revealed a less invasive growth pattern. Immunohistochemical analysis of a tissue microarray containing HCC and corresponding non-cancerous liver tissue of 85 patients confirmed reduced MIA2 expression in HCC. Furthermore, MIA2 negative HCC tissue showed a significantly higher Ki67 labelling index and loss of MIA2 expression correlated significantly with more advanced tumour stages. Conclusion: This study presents MIA2 as an inhibitor of HCC growth and invasion both in vitro and in vivo, and consequently, as a tumour suppressor of HCC. Further, our findings indicate a novel mechanism, how loss of HNF-1 expression in HCC affects tumorigenicity via down-regulation of MIA2.
ACCESSION #
28843120

 

Related Articles

  • An N-terminal Region of mot-2 Binds to p53 In Vitro. Kaul, Sunil C; Reddel, Roger R; Mitsui, Youji; Wadhwa, Renu // Neoplasia;Mar2001, Vol. 3 Issue 2, p110 

    The mouse mot-2 protein was earlier shown to bind to the tumor suppressor protein, p53. The mot-2 binding site of p53 was mapped to C-terminal amino acid residues 312–352, which includes the cytoplasmic sequestration domain. In the present study, we have found that both mot-1 and mot-2...

  • The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis. Habbous, Steven; Przech, Sebastian; Acedillo, Rey; Sarma, Sisira; Garg, Amit X.; Martin, Janet // Nephrology Dialysis Transplantation;Jan2017, Vol. 32 Issue 1, p111 

    Background. It remains unclear which phosphate binders should be preferred for hyperphosphatemia management in chronic kidney disease (CKD). Methods. We performed a systematic review and meta-analysis of randomized trials comparing sevelamer or lanthanum with other phosphate binders in CKD....

  • Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates. Weaver, Yi M.; Hagenbuch, Bruno // Journal of Membrane Biology;Aug2010, Vol. 236 Issue 3, p279 

    OATP1B1 and 1B3 are related transporters mediating uptake of numerous compounds into hepatocytes. A putative model of OATP1B3 with a "positive binding pocket" containing conserved positively charged amino acids was predicted (Meier-Abt et al. J Membr Biol 208:213-227, 2005). Based on this model,...

  • New mechanism of tolerance induction in cancer. Leavy, Olive // Nature Reviews Immunology;Aug2007, Vol. 7 Issue 8, p580 

    The article presents a study which examines the mechanism of myeloid-derived suppressor cells (MDSCs) in inducing CD8+ T-cell tolerance by blocking peptide-MHC-TCR (T-cell receptor) binding through the nitration of TCR-CD8 complex. The study utilizes an experimental mouse model to assess the...

  • The contribution of the RING finger domain of MDM2 to cell cycle progression. Argentini, Manuela; Barboule, Nadia; Wasylyk, Bohdan // Oncogene;8/10/2000, Vol. 19 Issue 34, p3849 

    The MDM2 oncoprotein binds to p53 and abrogates p53-mediated G1 arrest and apoptosis. We show that MDM2 over-expression accelerates cell cycle progression of RPMI2650 cells by overcoming the negative effect of endogenous wild type p53 at the G1/S checkpoint. The interaction with p53 and...

  • Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53. Drané, Pascal; Barel, Monique; Balbo, Michelle; Frade, Raymond // Oncogene;12/18/97, Vol. 15 Issue 25, p3013 

    Immunological screening with the anti-p53 moAb, PAb1801 of a cDNA expression library, prepared from human B lymphoma cells, led us to identify a new human 205 kDa protein called RB18A for ‘Recognized By PAb1801 moAntibody’ Immunoblotting or immunoprecipitation of fusion protein or...

  • Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins. Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: The Nse1, Nse3 and Nse4 proteins form a tight sub-complex of the large SMC5-6 protein complex. hNSE3/ MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and the Nse4 kleisin subunit is related to the EID (E1A-like...

  • The Majority of Autologous Cytolytic T-Lymphocyte Clones Derived from Peripheral Blood Lymphocytes of a Melanoma Patient Recognize an Antigenic Peptide Derived from Gene Pmel17/gp100. Zarour, Hassane; De Smet, Charles; Lehmann, Frédéric; Marchand, Marie; Lethé, Bernard; Romero, Pedro; Boon, Thierry; Renauld, Jean-Christophe // Journal of Investigative Dermatology;Jul96, Vol. 107 Issue 1, p63 

    Anti-melanoma cytolytic T-lymphocyte (CTL) clones were derived from peripheral blood lymphocytes of HLA-A2 melanoma patient LB265 after stimulation with the autologous tumor cell line LB265-MEL, which showed high expression of melanocyte-lineage specific genes. Of 55 CTL clones, 46 recognized...

  • Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins. Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: The Nse1, Nse3 and Nse4 proteins form a tight sub-complex of the large SMC5-6 protein complex. hNSE3/ MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and the Nse4 kleisin subunit is related to the EID (E1A-like...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics